AMPH
Amphastar P
NASDAQ: AMPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$23.90
+2.18% today
Updated 2026-05-06
Market cap
$974.42M
P/E ratio
10.78
P/S ratio
1.35x
EPS (TTM)
$2.03
Dividend yield
—
52W range
$17 – $31
Volume
0.6M
Amphastar P (AMPH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
13.60%
Operating margin
19.50%
ROE
12.90%
ROA
6.37%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $118.36M | $7.75M | 23.75% | -28.34% | 6.55% |
| 2012 | $204.32M | $18.09M | 44.20% | 12.43% | 8.86% |
| 2013 | $229.68M | $11.86M | 37.86% | 7.61% | 5.16% |
| 2014 | $210.46M | $-10.70M | 24.35% | -8.54% | -5.08% |
| 2015 | $251.52M | $-2.79M | 30.75% | -2.74% | -1.11% |
| 2016 | $255.16M | $10.53M | 40.83% | 6.15% | 4.13% |
| 2017 | $240.18M | $4.51M | 37.80% | -0.37% | 1.88% |
| 2018 | $294.67M | $-5.74M | 36.31% | -2.93% | -1.95% |
| 2019 | $322.36M | $48.94M | 40.92% | -0.01% | 15.18% |
| 2020 | $349.85M | $1.40M | 40.97% | 3.13% | 0.40% |
| 2021 | $437.77M | $62.12M | 45.63% | 15.96% | 14.19% |
| 2022 | $498.99M | $91.39M | 49.87% | 21.54% | 18.31% |
| 2023 | $644.39M | $137.54M | 54.49% | 30.57% | 21.34% |
| 2024 | $731.97M | $159.52M | 51.08% | 28.06% | 21.79% |
| 2025 | $719.89M | $98.09M | 49.46% | 19.50% | 13.63% |